A multi-centre, randomised, double-blind, placebo-controlled clinical trial on the efficacy and tolerability of GeloMyrtol® forte in acute bronchitis

Drug Research

Volumn 63, Issue 1, 2013, Pages 19-27

  Gillissen, A ^a   Wittig, Th ^b   Ehmen, M ^b   Krezdorn, H G ^c   De Mey, C ^d  

^a Department for Pulmonary Medicine   (Germany)

^b Arzt für Allgemeinmedizin   (Germany)

^c Kardiologische Praxis   (Germany)

^d ACPS Network GmbH Applied Clinical Pharmacology Services   (Germany)

Author keywords

acute bronchitis; clinical trial; GeloMyrtol forte; Myrtol

Indexed keywords

MYRTOL; PLACEBO; DRUG DERIVATIVE; MENTHOL;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BRONCHITIS; CONTROLLED STUDY; COUGHING; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERUCTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; ACUTE DISEASE; ADOLESCENT; CONTROLLED CLINICAL TRIAL; DRUG COMBINATION; MIDDLE AGED; VERY ELDERLY;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRONCHITIS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; MALE; MENTHOL; MIDDLE AGED;

MLCS; MLOWN;

EID: 84878887841     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0032-1331182     Document Type: Article

References (47)

1. Wenzel R. P., Fowler A. A. Acute bronchitis. N Engl J Med: 2006; 355 2125 2130
2. Kroening-Roche J. C., Soroudi A., Castillo E. M. et al. Antibiotic and Bronchodilator Prescribing for Acute Bronchitis in the Emergency Department. J Emerg Med Aug: 2012; 43 02 221 227
3. Roisin R. R., Vestbo J. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2011; Available from: http://www.goldcopd.org/
4. Matthys H., de Mey C., Carls C. et al. Efficacy and Tolerability of Standardized in Acute Bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol. Arzneim-Forsch/Drug Res: 2000; 50 II 8 700 711
5. Verheij TJ M., Kaptein A. A., Mulder J. D. Acute bronchitis: aetiology, symptoms and treatment. Fam Pract: 1989; 6 66 69
6. Braman S. S. Chronic cough due to acute bronchitis: ACCP evidence-based clinical practice guidelines. Chest: 2006; 129 01 95S 103S
7. German Summary of Product Characteristics (Fachinformation) GeloMyrtol®/GeloMyrtol® forte Aug: 2010
8. Kemmerich B., Eberhardt R., Stammer H. Efficacy and tolerability of a fluid extract combination of thyme herb and ivy leaves and matched placebo in adults suffering from acute bronchitis with productive cough. Arzneim.-Forsch./Drug Res: 2006; 56 09 652 660
9. Kemmerich B. Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial. Arzneim -Forsch/Drug Res: 2007; 57 09 607 615
10. Matthys H., Heger M. Treatment of acute bronchitis with a liquid herbal drug preparation from Pelargonium sidoides (EP 7630): a randomised, double-blind, placebo-controlled, multicenter study. Current Medical research and Opinions: 2007; 23 02 323 331
11. Gruenwald J., Graubaum H. J., Busch R. Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis. Arzneim.-Forsch./Drug Res: 2005; 55 11 669 676
12. Gruenwald J., Graubaum H. J., Busch R. Evaluation of the Non-inferiority of a Fixed Combination of Thyme Fluid- and Primrose Root Extract in Comparison to a Fixed Combination of Thyme Fluid Extract and Primrose Root Tincture in Patients with Acute Bronchitis. Arzneim -Forsch/Drug Res: 2006; 56 No. 8 574 581
13. Kardos P., Cegla U., Gillissen A. et al. Leitlinie der Deutschen Gesellschaft für Pneumologie zur Diagnostik und Therapie von Patienten mit akutem und chronischem Husten. Pneumologie: 2004; 58 570 602
14. Gillissen A. Akute Bronchitis. In Reuter P. Hrsg Springer Lexikon Diagnose & Therapie. 1. Auflage Springer Berlin Heidelberg: 2006; Part 1, Part 2, Seiten 165 174
15. Macfarlane J. T., Holmes W. F., Macfarlane R. M. et al. Contemporary use of antibiotics in 1089 adults presenting with acute lower respiratory tract illness in primary care in the UK: implications for developing management guidelines. Respir Med: 1997; 91 427 434
16. Macfarlane J., Holmes W., Macfarlane R. et al. Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. BMJ: 1997; 315 1211 1214
17. Kardos P., Berck H., Fuchs K. H. et al. Leitlinie der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin zur Diagnostik und Therapie von erwachsenen Patienten mit akutem und chronischem Husten. Pneumologie: 2010; 64 336 373
18. Knutson D., Braun C. Diagnosis and Management of Acute Bronchitis. Am Fam Physician: 2002; 65 2039 2045
19. th ed. New York Churchill Livingstone: 1995; 606 608
20. Hueston W. J., Mainous A. G. IIIrd. Acute Bronchitis. Am Fam Physician Mar 15: 1998; 57 06 1270 1276 1281-1282
21. Adam D., Bodmann K. F., Elies W. et al. Praxisorientierte Empfehlungen zur kalkulierten Initialtherapie bakterieller Erkrankungen der Atemwege und des HNO-Bereichs bei Erwachsenen. Arzneimitteltherapie: 2005; 23 247 255
22. Arzneimittelkommission der deutschen Ärzteschaft: Handlungsleitlinie Atemwegsinfektionen aus Empfehlungen zur Therapie akuter Atemwegsinfektionen Arzneiverordnung in der Praxis, Sonderheft, 2. Auflage; 2002
23. Vogel F., Worth H., Adam D. et al. Rationale Therapie bakterieller Atemwegsinfektionen. Chemotherapie Journal: 2000; 9 01 3 23
24. Orr P. H., Scherer K., Macdonald A. et al. Randomized Placebo-controlled trials of antibiotics for acute bronchitis: a critical review of the literature. J Fam Pract: 1993; 36 507 512
25. Smith S. M., Fahey T., Smucny J. et al. Editorial Group: Cochrane Acute Respiratory Infections Group Antibiotics for acute bronchitis. 2009 Jan 21: CD000245
26. Belongia E. A., Schwartz B. Strategies for promoting judicious use of antibiotics by doctors and patients. BMJ: 1998; 317 668 671
27. Huovinen P., Cars O. Editorials - Control of antimicrobial resistance: time for action. BMJ: 1998; 317 613 614
28. Wise R., Hart T., Cars O. et al. Antimicrobial resistance is a major threat to public health. BMJ: 1998; 317 609 610
29. Webb S., Lloyd M. Prescribing and referral in general practice: a study of patients' expectations and doctors' actions. Br J Gen Pract: 1994; 44 165 169
30. Rapaport J. Patients' expectations and intention to self medicate. J R Coll Gen Pract: 1979; 29 468 472
31. Meister R., Wittig Th, Beuscher N. et al. Wirksamkeit und Verträglichkeit von Myrtol standardisiert bei der Langzeitbehandlung der chronischen Bronchitis, Arzneim.-Forsch./Drug Res. 1999; 49 0I 4: 351 358
32. Federspil P., Wulkow R., Zimmermann Th et al. Efficacy of Myrtol Standardized in the Therapy of Acute Sinusitis - Results of a Double-Blind, Randomized, Placebo-Controlled, Multicentric Study. Laryngo-Rhino-Otol: 2000; 79 1 5
33. Wittig Th. Myrtol standardisiert - Eine klinische Dokumentation, Ergebnisse Verlag. 5. Auflage: 2010
34. Behrbohm H., Kaschke O., Sydow K. Der Einfluß des pflanzlichen Sekretolytikums Gelomyrtol® forte auf die mukoziliäre Clearance der Kieferhöhle. Laryngo-Rhino-Otol: 1995; 74 733 737
35. st Edition: 2000; 27 53
36. Behrbohm H., Kaschke O., Sydow K. The influence of a secretolytic drug on mucociliary clearance of the maxillary sinus. J Rhinol: 1997; 4 01 29 33
37. Cao L., Chen Y., Zhao Y. et al. Effect of Myrtol standardized on mucus hypersecretion and clearance of Pseudomonas aeruginosa in a rat model of chronic obstructive pulmonary disease. Arzneim Forsch/Drug Research: 2011; 61 12 685 692
38. Dorow P., Th Weiss, Felix R. et al. Einfluß eines Sekretolytikums und einer Kombination von Pinen, Limonen und Cineol auf die mukoziliare Clearance bei Patienten mit chronisch obstruktiver Atemwegserkrankung. Arzneim Forsch/Drug Research: 1987; 37 11 1378 1381
39. Begrow F., Böckenholt C., Ehmen M. et al. Effect of Myrtol Standardized and Other Substances on the Respiratory Tract: Ciliary Beat Frequency and Mucociliary Clearance as Parameters. Adv Ther: 2012
40. Kwok R. P. The effects of Gelomyrtol forte® on human ciliary beat frequency and intracellular cyclic adenosine monophosphate in vitro. Dissertation for the degree of Master of Research in Medicine. Division of Respiratory Medicine, Department of Medicine, Queen Mary Hospital, Hong Kong: 2007
41. Rantzsch U., Vacca G., Dück R. et al. Anti-inflammatory effects of Myrtol standardized and other essential oils on alveolar macrophages from patients with chronic obstructive pulmonary disease. Eur J Med Res: 2009; 14 04 205 209
42. Juergens U. R., Stöber M., Vetter H. Steroidartige Hemmung des monozytären Arachidonsäuremetabolismus und der IL-1ß-Produktion durch 1.8-Cineol. Atemw-Lungenkrkh: 1998; 24 3 11
43. Beuscher N., Kietzmann M., Bien E. et al. Interference of Myrtol standardised with inflammatory and allergic mediators. Arzneim-Forsch/Drug Res: 1998; 48 0I 985 989
44. Beuscher N., Bien E., Elstner E. F. et al. Myrtol standardized in treatment of sinusitis and bronchitis - Pharmacodynamics and pharmacokinetics, Zeitschrift für Phytotherapie. Abstractband, Kongress der Gesellschaft für Phytotherapie: 1997; 9 10
45. Graßmann J., Hippeli S., Dornisch K. et al. Antioxidant Properties of Essential Oils. Arzneim-Forsch/Drug Res: 2000; 50 0I 135 139
46. Christoph F., Kaulfers P-M, Stahl-Biskup E. In vitro evaluation of the antibacterial activity of β-triketones admixed to Melaleuca oils. Planta Medica: 2001; 67 08 768 771
47. Beuscher N., Bien E., Vierling T. H. Myrtol standardized in treatment of sinusitis and bronchitis - Safety and Toxicology. Zeitschrift für Phytotherapie, Abstract Volume, Congress of the Gesellschaft für Phytotherapie: 1997; 7 8